Roche booming thanks to the rush for Tamiflu

My Account
Logout

Create an Evening Standard Account

Use your social network

Save time by using your existing account to sign in to Evening Standard

We'll never share your information or post anything to your account without your permission

Welcome! Sign in here

Use your social network

Save time by using your existing account to sign in to Evening Standard

We'll never share your information or post anything to your account without your permission

Forgot your password ?

Registration

* indicates fields that are mandatory

Email *

Password *

Confirm Password *

First name *

Surname *

Postcode *

Country *

Mobile phone number

Username *

Gender *

Year of birth *

When you sign up...

You will have access to all our online competitions, discounted offers and can post comments on our site.

You will also receive The Weekender newsletter sent every Thursday - it’s full of fantastic offers and ideas for the weekend. You can update your email preferences in your account page when you log in.

Other newsletters and emails

Homes & Property Newsletter - Yes I want to receive the weekly email with all the latest news on property in the capital

Occasionally we would also like to send you relevant emails detailing specific offers either from ourselves or carefully selected partners. If you would prefer not to receive these then please tick the appropriate boxes below. We will never pass on your details.

I do not want to receive additional offers and information from the Evening Standard

I do not want to receive additional offers and information sent by Evening Standard on behalf of carefully selected partners

Terms and Conditions

* I have read, understood and agree to be bound by the terms and conditions of Evening Standard

Registration

Mail Sent for Registration Confirmation.

A confirmation email has been sent. Please activate your account by clicking on the activation link sent in your mail box.

Tamiflu sales for the full year were now expected to come in at Swfr2.7 billion, up from Swfr2 billion before.

Roche said "strong demand" for its pandemic medicine would now be pushing through "at least high single digit full-year sales growth". Investors had been predicting a third-quarter revenue figure of Swfr12.18 billion. Demand for the anti-viral drug has soared since swine flu was first identified in April.

In the UK Roche has sold 23 million batches to the Department of Health, while global stockpiling of Tamiflu helped sales in the third quarter reach Swfr994 million, compared with Swfr101 million in the same period last year.

That helped cancer drug-specialist Roche post a 9.7% rise in third-quarter revenue. It was boosted by a 26% rise in sales of Avastin, a medicine for patients with advanced bowel and kidney cancer, which made Roche Swfr4.683 billion, and by breast cancer drug Herceptin, up 9%, as sales hit Swfr3.972 billion.